Article Text

Download PDFPDF
Medicines Delivery Proximity Programme (PEMProxi) survey results
  1. Sebastião Silva,
  2. Margarida Abreu,
  3. Ana Paula Dinis,
  4. Rosângela Garcia,
  5. Manuela Rodrigues,
  6. Clara Sequeira,
  7. José Feio
  1. Department of Pharmacy, Coimbra Hospital and University Center, Coimbra, Portugal
  1. Correspondence to Dr Sebastião Silva, Departamento de Farmácia, Centro Hospitalar e Universitário de Coimbra EPE, Coimbra, Portugal; ssilva{at}


Objectives To evaluate patients’ and community pharmacies’ satisfaction towards the Medicines Delivery Proximity Programme (PEMProxi), including patients’ level of satisfaction with pharmaceutical services, medication dispensing and delivery, cost, and time saved, community pharmacies’ satisfaction with PEMProxi-related information and procedures, contact with the patients, and timings. Additionally, to evaluate patients’ and community pharmacies’ perception of PEMProxi’s advantages and disadvantages.

Methods Patients and the community pharmacies included in PEMProxi were contacted by telephone to answer a survey. The patient survey included questions regarding their satisfaction level towards PEMProxi, medication dispensing and delivery, and cost and time saved. Patients were also asked to point out the advantages and disadvantages of PEMProxi and give improvement suggestions. The community pharmacy survey included questions regarding satisfaction with entering PEMProxi, related information, procedures, contact with the patients on PEMProxi, and timings. Programme-related advantages, disadvantages and improvement suggestions were also solicited.

Results A total of 101 patients and 49 community pharmacies were included in the analysis. A large majority of patients were very satisfied with PEMProxi (93.1%). The Programme allowed each patient to save on average 30€ and 8 hours per month. More than 95% of the patients reported medication delivery in adequate conditions (n=100), in a timely manner (n=95) and according to the prescription (n=95). Most pharmacies were satisfied or very satisfied with their participation in PEMProxi (63.3%). Nearly half (53.1%) were surprised by its implementation and 98% would be available to participate with more patients if the Programme was extended.

Conclusions The PEMProxi programme contributed to more convenient and equitable access to medications by chronic patients, thus avoiding unnecessary trips to the hospital, saving them precious time and money.

  • hospital distribution systems
  • medication systems
  • hospital
  • pharmacy service
  • hospital
  • quality of health care
  • HIV
  • medical oncology

Data availability statement

No data are available. Not applicable.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.